{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:49:57Z","timestamp":1770428997059,"version":"3.49.0"},"reference-count":20,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:p>OSA (obstructive sleep apnoea) stimulates sympathetic nervous activity and elevates resting HR (heart rate) and BP (blood pressure). In the present study in a cohort of 309 untreated OSA patients, the resting HR and BP during the daytime were correlated with AHI (apnoea\/hypopnea index) and compared with patients with R389R (n=162), R389G (n=125) and G389G (n=22) genotypes of the \u03b21-adrenoreceptor R389G polymorphism. We analysed the impact of the genotype on the decline of HR and BP in a subgroup of 148 patients (R389R, n=86; R389G, n=54; G389G, n=8) during a 6-month follow-up period under CPAP (continuous positive airway pressure) therapy during which cardiovascular medication remained unchanged. In untreated OSA patients, we found an independent relationship between AHI and resting HR (\u03b2=0.096, P&amp;lt;0.001), systolic BP (\u03b2=0.09, P=0.021) and diastolic BP (\u03b2=0.059, P=0.016). The resting HR\/BP, however, did not differ among carriers with the R389R, R389G and G389G genotypes. CPAP therapy significantly reduced HR [\u22122.5 (\u22121.1 to \u22124.0) beats\/min; values are mean difference (95% confidence intervals)] and diastolic BP [\u22123.2 (\u22121.5 to \u22125.0) mmHg]. The decline in HR was more significantly pronounced in the R389R group compared with the Gly389 carriers [\u22124.1 (\u22122.3 to \u22125.9) beats\/min (P&amp;lt;0.001) compared with \u22120.2 (2.1 to \u22122.6) beats\/min (P=0.854) respectively; Student's t test between groups, P=0.008]. Diastolic BP was decreased significantly (P&amp;lt;0.001) only in Gly389 carriers (R389G or G389G) compared with R389R carriers [\u22125.0 (\u22122.3 to \u22127.6) mmHg compared with \u22122.0 (0.4 to \u22124.3) mmHg respectively]. ANOVA revealed a significant difference (P=0.023) in HR reduction between the three genotypes [\u22124.1 (\u00b18.4) beats\/min for R389R, \u22120.5 (\u00b19.3) beats\/min for R389G and +1.9 (\u00b17.2) beats\/min for G389G]. In conclusion, although the R389G polymorphism of the \u03b21-adrenoceptor gene did not influence resting HR or BP in untreated OSA patients, it may modify the beneficial effects of CPAP therapy on these parameters.<\/jats:p>","DOI":"10.1042\/cs20050244","type":"journal-article","created":{"date-parts":[[2005,12,14]],"date-time":"2005-12-14T12:57:04Z","timestamp":1134565024000},"page":"117-123","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Modifying effects of the R389G \u03b21-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea"],"prefix":"10.1042","volume":"110","author":[{"given":"Jan","family":"B\u00f6rgel","sequence":"first","affiliation":[{"name":"Medical Clinic 2, Cardiology and Angiology, St Josef Hospital\/Bergmannsheil, Ruhr University, Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tino","family":"Schulz","sequence":"additional","affiliation":[{"name":"Medical Clinic 2, Cardiology and Angiology, St Josef Hospital\/Bergmannsheil, Ruhr University, Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina\u00a0K.","family":"Bartels","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Ruhr University, Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg\u00a0T.","family":"Epplen","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Ruhr University, Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"B\u00fcchner","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars\u00a0Christian","family":"Rump","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika","family":"Huesing","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics and Biometrics, Ruhr University, Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd\u00a0M.","family":"Sanner","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, Bethesda Hospital, Wuppertal, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"M\u00fcgge","sequence":"additional","affiliation":[{"name":"Medical Clinic 2, Cardiology and Angiology, St Josef Hospital\/Bergmannsheil, Ruhr University, Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2005,12,12]]},"reference":[{"key":"2021120120515027400_B1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/00004872-199715120-00060","article-title":"Hypertension caused by chronic intermittent hypoxia: influence of chemoreceptors and sympathetic nervous system","volume":"15","author":"Lesske","year":"1997","journal-title":"J. Hypertens."},{"key":"2021120120515027400_B2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI118235","article-title":"Sympathetic neural mechanisms in obstructive sleep apnea","volume":"96","author":"Somers","year":"1995","journal-title":"J. Clin. Invest."},{"key":"2021120120515027400_B3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-201X.2003.01091.x","article-title":"Sympathetic nerve activity in obstructive sleep apnoea","volume":"177","author":"Narkiewiczand","year":"2003","journal-title":"Acta Physiol. Scand."},{"key":"2021120120515027400_B4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/sleep\/20.3.224","article-title":"Sleep apnea, norepinephrine-release rate, and daytime hypertension","volume":"7","author":"Ziegler","year":"1997","journal-title":"Sleep"},{"key":"2021120120515027400_B5","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"2021120120515027400_B6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/aje\/154.1.50","article-title":"Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study","volume":"154","author":"Newmann","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"2021120120515027400_B7","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1074\/jbc.274.18.12670","article-title":"A gain-of-function polymorphism in a G-protein coupling domain of the human \u03b21-adrenergic receptor","volume":"274","author":"Mason","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2021120120515027400_B8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bjp.0705031","article-title":"Receptor gene polymorphisms: lessons on functional relevance from \u03b21-adrenoceptor","volume":"138","author":"Michel","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"2021120120515027400_B9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/sleep\/22.5.667","article-title":"Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research","volume":"22","author":"ForceM AAoSMT","year":"1999","journal-title":"Sleep"},{"key":"2021120120515027400_B10","article-title":"A manual of standardized terminology techniques and scoring systems for sleep stages of human subjects, NIH publication no. 204","author":"Rechtschaffen","year":"1968"},{"key":"2021120120515027400_B11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.bjp.0705030","article-title":"Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 \u03b21-adrenoceptors versus Gly389 \u03b21-adrenoceptors in isolated human atrial myocardium","volume":"138","author":"Sandilands","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"2021120120515027400_B12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.CIR.104.2.187","article-title":"Polymorphism in the \u03b21-adrenergic receptor gene and hypertension","volume":"104","author":"Bengtsson","year":"2001","journal-title":"Circulation"},{"key":"2021120120515027400_B13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/339621","article-title":"A polymorphism in the \u03b21-adrenergic receptor is associated with resting heart rate","volume":"70","author":"Ranade","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"2021120120515027400_B14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00008571-200104000-00003","article-title":"In-vivo studies do not support a major role for the Gly389Arg \u03b21-adrenoceptor polymorphism in humans","volume":"11","author":"Buscher","year":"2001","journal-title":"Pharmacogenetics"},{"key":"2021120120515027400_B15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/CS20020299","article-title":"Effects of common polymorphisms in the \u03b11A-, \u03b12B, \u03b21- and \u03b22-adrenoceptors on haemodynamic responses to adrenaline","volume":"104","author":"Snapir","year":"2003","journal-title":"Clin. Sci."},{"key":"2021120120515027400_B16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","article-title":"Sleep disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study","volume":"163","author":"Shahar","year":"2001","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"2021120120515027400_B17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/sleep\/18.3.149","article-title":"Mortality in sleep apnea patients: a multivariate analysis of risk factors","volume":"18","author":"Lavie","year":"1997","journal-title":"Sleep"},{"key":"2021120120515027400_B18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(05)71141-7","article-title":"Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study","volume":"365","author":"Marin","year":"2005","journal-title":"Lancet"},{"key":"2021120120515027400_B19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.04.00015604","article-title":"Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients","volume":"23","author":"Heitmann","year":"2004","journal-title":"Eur. Respir. J."},{"key":"2021120120515027400_B20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0895-7061(02)03267-3","article-title":"Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea","volume":"16","author":"Moller","year":"2003","journal-title":"Am. J. Hypertens."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/110\/1\/117\/437694\/cs1100117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/110\/1\/117\/437694\/cs1100117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T21:57:31Z","timestamp":1638395851000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/110\/1\/117\/68464\/Modifying-effects-of-the-R389G-1-adrenoceptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20050244","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,12]]}}}